
Engineering Clinical Development for Novel Therapeutics: CGT and Beyond
As the cell and gene therapy (CGT) field continues to mature, many companies face a growing tension between scientific innovation and the realities of clinical development. Unsustainable costs, limited access to specialized expertise and outdated …